Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Jan;33(1):9-16.
doi: 10.2337/dc09-1407. Epub 2009 Oct 21.

Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial

Janet A Rowan  1 , Wanzhen Gao, William M Hague, Harold David McIntyre
Affiliations
Randomized Controlled Trial

Glycemia and its relationship to outcomes in the metformin in gestational diabetes trial

Janet A Rowan et al. Diabetes Care. 2010 Jan.

Abstract

Objective: To determine how glucose control in women with GDM treated with metformin and/or insulin influenced pregnancy outcomes.

Research design and methods: Women randomly assigned to metformin or insulin treatment in the Metformin in Gestational Diabetes (MiG) trial had baseline glucose tolerance test (OGTT) results and A1C documented, together with all capillary glucose measurements during treatment. In the 724 women who had glucose data for analysis, tertiles of baseline glucose values and A1C and of mean capillary glucose values during treatment were calculated. The relationships between maternal factors, glucose values, and outcomes (including a composite of neonatal complications, preeclampsia, and large-for-gestational-age [LGA] and small-for-gestational-age infants) were examined with bivariable and multivariate models.

Results: Baseline OGTT did not predict outcomes, but A1C predicted LGA infants (P = 0.003). During treatment, fasting capillary glucose predicted neonatal complications (P < 0.001) and postprandial glucose predicted preeclampsia (P = 0.016) and LGA infants (P = 0.001). Obesity did not influence outcomes, and there was no interaction between glycemic control, randomized treatment, or maternal BMI in predicting outcomes. The lowest risk of complications was seen when fasting capillary glucose was <4.9 mmol/l (mean +/- SD 4.6 +/- 0.3 mmol/l) compared with 4.9-5.3 mmol/l or higher and when 2-h postprandial glucose was 5.9-6.4 mmol/l (6.2 +/- 0.2 mmol/l) or lower.

Conclusions: Glucose control in women with gestational diabetes mellitus treated with metformin and/or insulin is strongly related to outcomes. Obesity is not related to outcomes in this group. Targets for fasting and postprandial capillary glucose may need to be lower than currently recommended.

PubMed Disclaimer

References

    1. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477– 2486 - PubMed
    1. Langer O, Yogev Y, Most O, Xenakis EM: Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 2005; 192: 989– 997 - PubMed
    1. Kjos SL, Schaefer-Graf UM: Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care 2007; 30( Suppl. 2): S200– S205 - PubMed
    1. Hod M, Yogev Y: Goals of metabolic management of gestational diabetes: is it all about the sugar? Diabetes Care 2007; 30( Suppl. 2): S180– S187 - PubMed
    1. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30 2007( Suppl. 2): S251– S260 - PubMed

Publication types